169 related articles for article (PubMed ID: 32955002)
1. Vitamin D Represses the Aggressive Potential of Osteosarcoma.
Tahbazlahafi B; Paknejad M; Khaghani S; Sadegh-Nejadi S; Khalili E
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1312-1318. PubMed ID: 32955002
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
Salehi-Tabar R; Nguyen-Yamamoto L; Tavera-Mendoza LE; Quail T; Dimitrov V; An BS; Glass L; Goltzman D; White JH
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18827-32. PubMed ID: 23112173
[TBL] [Abstract][Full Text] [Related]
3. Propofol suppresses osteosarcoma cell function by regulating FOXO1/TUSC7.
Huang X; Liu J; Xie H
J Pharm Pharmacol; 2021 Apr; 73(6):720-725. PubMed ID: 33724400
[TBL] [Abstract][Full Text] [Related]
4. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
[TBL] [Abstract][Full Text] [Related]
5. Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.
Li Z; Liu H; Li B; Zhang Y; Piao C
Cell Biochem Biophys; 2015 Jul; 72(3):719-26. PubMed ID: 25627547
[TBL] [Abstract][Full Text] [Related]
6. Snail-1 regulates VDR signaling and inhibits 1,25(OH)-D₃ action in osteosarcoma.
Yang H; Zhang Y; Zhou Z; Jiang X; Shen A
Eur J Pharmacol; 2011 Nov; 670(2-3):341-6. PubMed ID: 21963453
[TBL] [Abstract][Full Text] [Related]
7. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.
He P; Wang Z; Sheng B; Xu Y; Feng S; Huang Y; Gong F; Tang L; Xie L
Histol Histopathol; 2020 Dec; 35(12):1511-1520. PubMed ID: 33372687
[TBL] [Abstract][Full Text] [Related]
8. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
9. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Liu B; Xu L; Dai EN; Tian JX; Li JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
[TBL] [Abstract][Full Text] [Related]
11. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
12. Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
Lan H; Hong W; Fan P; Qian D; Zhu J; Bai B
Cell Physiol Biochem; 2017; 43(2):553-567. PubMed ID: 28965117
[TBL] [Abstract][Full Text] [Related]
13. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
14. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
15. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
16. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.
Meyer MB; Goetsch PD; Pike JW
Mol Endocrinol; 2012 Jan; 26(1):37-51. PubMed ID: 22108803
[TBL] [Abstract][Full Text] [Related]
17. Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway.
Gumireddy K; Ikegaki N; Phillips PC; Sutton LN; Reddy CD
Biochem Pharmacol; 2003 Jun; 65(12):1943-55. PubMed ID: 12787874
[TBL] [Abstract][Full Text] [Related]
18. FOXO1-MALAT1-miR-26a-5p Feedback Loop Mediates Proliferation and Migration in Osteosarcoma Cells.
Wang J; Sun G
Oncol Res; 2017 Nov; 25(9):1517-1527. PubMed ID: 28160461
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.
Long C; Chen J; Zhou H; Jiang T; Fang X; Hou D; Liu P; Duan H
Cell Cycle; 2019 Feb; 18(3):346-358. PubMed ID: 30640578
[TBL] [Abstract][Full Text] [Related]
20. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
